In vivo differentiation of magnetically labeled mesenchymal stem cells into hepatocytes for cell therapy to repair damaged liver.
PMID 20808237 · Investigative radiology · 2010 · DOI 10.1097/RLI.0b013e3181ed55f4
Authors: Shenghong Ju; Gao-Jun Teng; Haihua Lu; JiYang Jin; Yu Zhang; Aifeng Zhang; Yicheng Ni
Abstract
It was unclear whether systemically administered mesenchymal stem cells (MSCs) labeled with magnetic nanoparticles can transdifferentiate into hepatocytes. In the present study, we built a new in vivo murine model for monitoring the transdifferentiation of magnetically labeled green fluorescent protein (GFP) positive MSCs into albumin-positive hepatocytes, under the carbon tetrachloride (CCl4) induced persistent liver damage. We also tracked magnetically labeled MSCs by using magnetic resonance imaging (MRI) in vivo. Among the liver damage groups, magnetically labeled GFP-positive MSCs (group A), GFP-positive MSCs (group B), and saline alone (group C) were intravenously injected. In control groups without CCl4 administration magnetically labeled GFP-positive MSCs (group D) were infused, whereas nothing was given in group E. MRI examinations were performed 24 hours and 4 weeks after cell injection in group A, B, and C. Liver-to-muscle contrast-to-noise ratios on T2*-weighted MR images were measured. At 4 weeks, 3 serum biologic liver function markers were analyzed, and mice in all groups were killed for histologic examination. The results showed that migration of transplanted magnetic labeled cells to the liver was successfully documented with in vivo MRI. Serum liver function markers were changed for all liver damage groups than nondamage control groups (P < 0.05), but still insignificant compared with group C (P > 0.05). Hematoxylin and eosin and Masson staining confirmed the presence of liver damage and hepatic fibrosis in group A, B, and C. Positive Prussian blue stained cells were highly correlated with GFP-positive cells in group A with an average matching rate of 95%. In group D, no iron-GFP-positive cells can be found in the liver. Albumin was expressed in (34% ± 6%) and (35% ± 7%) of GFP-positive cells in group A and B, respectively, and there was no significant difference between the 2 groups. Our data demonstrate that magnetic labeling technique synchronized well in GFP expressing MSCs and did not interfere with the transdifferentiation process and amending function of MSCs in vivo. Both magnetically labeled and unlabeled MSCs appeared to have the potential to differentiate into hepatocytes.
Animals; Biomarkers; Cell- and Tissue-Based Therapy; Disease Models, Animal; Female; Ferric Compounds; Hepatocytes; Immunohistochemistry; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Magnetic Resonance Imaging; Mesenchymal Stem Cell Transplantation; Mice; Mice, Inbred BALB C; Nanoparticles; Radionuclide Imaging
Cite
Shenghong Ju; Gao-Jun Teng; Haihua Lu; JiYang Jin; Yu Zhang; Aifeng Zhang; Yicheng Ni. In vivo differentiation of magnetically labeled mesenchymal stem cells into hepatocytes for cell therapy to repair damaged liver. Investigative radiology (2010). PMID 20808237. DOI 10.1097/RLI.0b013e3181ed55f4.